PPT-Glycemic Management in

Type 2 Diabetes Efficacy and Safety of Modern Antihyperglycemic Therapies DPP4 Inhibitors Glycemic Management in Type 2 Diabetes Efficacy and Safety of Modern Antihyperglycemic Therapies DPP4 Inhibitors. 1. AACE Comprehensive Care Plan. 2. Handelsman Y, et al. . Endocr Pract. . 2011;17(suppl 2):1-53.. Glycemic Management in Type 2 Diabetes. Therapeutic Lifestyle Change. 3. Components of Therapeutic Lifestyle Change. 1. J. V Akinlotan, . 2. I.O Olayiwola, . 3. A Ladokun and . 4. S.A Sanni . 1. Nutrition and Dietetics Department, Moshood Abiola Polytechnic Abeokuta. 2,4. Nutrition and Dietetics Department, Federal University of Agriculture Abeokuta. 1c. Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes. Goals. HbA. 1c. Targets: HEDIS and ADA. Objectives for Treatment of T2D. ADA/EASD Recommendations for HbA. 1c. Approach for Individualizing Glycemic Targets. Glycemic. Variability for Diabetes Management. Matthew Wiley, . Razvan. . Bunescu. , Cindy Marling,. Jay . Shubrook. and Frank Schwartz. School of Electrical Engineering and Computer Science. Appalachian Rural Health Institute Diabetes and Endocrine Center. Glimepiride, Metformin & . Voglibose. Combination in T2DM. Dr. Mohammed Riyaz . M.D (Medicine), Masters . in . Endocrinology(UK). Chief . Endocrinologist. & Medical Director (EDSC). Type 2 diabetes population requiring stringent . 1. AACE Comprehensive Care Plan. Handelsman YH, et al. . Endocr Pract. . 2015;21(suppl 1):1-87.. 2. Therapeutic Lifestyle Change. Glycemic Management of Type 2 Diabetes. 3. Components of Therapeutic Lifestyle Change. 1. AACE Comprehensive Care Plan. Handelsman YH, et al. . Endocr Pract. . 2015;21(suppl 1):1-87.. 2. Therapeutic Lifestyle Change. Glycemic Management of Type 2 Diabetes. 3. Components of Therapeutic Lifestyle Change. National Center for Health in Public Housing Clinical Quality Working Group. Diabetes in PHPC Settings. HBA1c>9 in PHPC Settings. American Diabetes Association’s Press Release. The ADA has long recommended that treatment goals be individualized based on factors both modifiable and nonmodifiable, such as age, life expectancy, duration of disease, resources and support, and comorbid conditions. The ADA recommends that a reasonable A1C goal for many nonpregnant adults with type 2 diabetes is less than 7 percent based on the available evidence to date from the ACCORD, ADVANCE, VADT and UKPDS international clinical trials, which were evaluated and incorporated into ADA’s Standards of Care. . PortionCarbohydratesGIBreadsBread, pumpernickel1 slice11 gBread, white or wheat1 slice13 gBread, whole wheat1 slice14 gTortilla, corn1 (small)24 gTortilla, wheat1 (small)26 gCerealsBran buds1/3 cup18 INTRODUCTION The concept of the glycemic index (GI) wasintroduced as a means of classifying carbohydrate containingfoods based on the blood glucose response after food consump-tion. The GI is define : Long-term hyperglycemia promotes development of complications and suboptimal well-being in patients with diabetes. A stringent glycemic control is a worldwide standard of diabetes care recommended i Eileen Egan. , DNP, FNP-C, BC-ADM, CDE, FAADE. Eileen Egan, DNP, FNP-C, BC-ADM, CDE, FAADE. Director, . Diabetes Education for the Faculty Practices. NYU Winthrop. Mineola, NY. Disclosure to Participants. Karl Hamouche, founder. www.swimsmarttoday.com. About Karl. Biology Undergrad at Iowa state university. 1 year of exercise science graduate work. Medical school at the University of Iowa. Resident in Wichita, Kansas. Agent-Specific Considerations. Joshua J. Neumiller, PharmD, CDE, FAADE, FASCP. Vice-Chair & Associate Professor. College of Pharmacy and Pharmaceutical Sciences . Washington State University. Presenter Disclosure Information.